Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative NetworkResearch in context

Summary: Background: Patients with rheumatoid arthritis (RA) are at increased risk of developing herpes zoster (HZ). This study aimed to assess the effectiveness of recombinant zoster vaccine (RZV) in reducing both the incidence of HZ and all-cause mortality among individuals with RA. Methods: We c...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ying-Li Lin, Shiow-Ing Wang, James Cheng-Chung Wei
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-07-01
Serija:	EClinicalMedicine
Teme:	Rheumatoid arthritis Herpes zoster Recombinant zoster vaccine Mortality
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2589537025002512
Oznake:	Označite Brez oznak, prvi označite!